Choreo LLC Grows Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Choreo LLC grew its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 38.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,052 shares of the medical instruments supplier’s stock after purchasing an additional 1,392 shares during the quarter. Choreo LLC owned about 0.09% of Mesa Laboratories worth $667,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of MLAB. Pacer Advisors Inc. increased its holdings in shares of Mesa Laboratories by 4.3% during the 4th quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier’s stock worth $231,000 after buying an additional 73 shares during the last quarter. Berry Wealth Group LP increased its holdings in shares of Mesa Laboratories by 5.3% during the 4th quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier’s stock worth $219,000 after buying an additional 83 shares during the last quarter. Amalgamated Bank increased its holdings in shares of Mesa Laboratories by 6.5% during the 3rd quarter. Amalgamated Bank now owns 1,588 shares of the medical instruments supplier’s stock worth $206,000 after buying an additional 97 shares during the last quarter. FMR LLC increased its holdings in shares of Mesa Laboratories by 34.1% during the 3rd quarter. FMR LLC now owns 393 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 100 shares during the last quarter. Finally, Public Sector Pension Investment Board increased its holdings in Mesa Laboratories by 1.8% in the 3rd quarter. Public Sector Pension Investment Board now owns 11,461 shares of the medical instruments supplier’s stock valued at $1,488,000 after purchasing an additional 200 shares during the last quarter. 90.60% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, November 13th.

Mesa Laboratories Stock Up 4.7 %

Mesa Laboratories stock opened at $154.76 on Tuesday. Mesa Laboratories, Inc. has a fifty-two week low of $83.68 and a fifty-two week high of $155.12. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.51 and a current ratio of 0.71. The firm has a 50 day moving average price of $135.42 and a 200 day moving average price of $126.57. The company has a market capitalization of $840.97 million, a PE ratio of -3.35 and a beta of 0.83.

Mesa Laboratories (NASDAQ:MLAB) last posted its earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. Research analysts expect that Mesa Laboratories, Inc. will post 7.39 earnings per share for the current year.

Mesa Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, February 28th will be paid a $0.16 dividend. The ex-dividend date is Friday, February 28th. This represents a $0.64 annualized dividend and a dividend yield of 0.41%. Mesa Laboratories’s dividend payout ratio (DPR) is -1.38%.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.